Prognostic implications of the phosphatidylinositol 3-kinase/Akt signaling pathway in oral squamous cell carcinoma: overexpression of p-mTOR indicates an adverse prognosis
Authors:
Open Access
- 30 November 2017
- journal article
- research article
- Published by Springer Nature in Applied Cancer Research
- Vol. 37 (1) , 1-8
Abstract
No abstract availableKeywords
Funding Information
- Fundação de Amparo à Pesquisa do Estado de São Paulo (2012/03260-0)
This publication has 27 references indexed in Scilit:
- Targeting the PI3K/AKT/mTOR pathway in squamous cell carcinoma of the head and neckOral Oncology, 2015
- Survival impact of cervical metastasis in squamous cell carcinoma of hard palateOral Surgery, Oral Medicine, Oral Pathology and Oral Radiology, 2013
- Effects of celecoxib treatment over the AKT pathway in head and neck squamous cell carcinomaJournal of Oral Pathology & Medicine, 2013
- PTEN Deficiency Contributes to the Development and Progression of Head and Neck CancerNeoplasia, 2013
- Biomarker-Directed Therapy of Squamous Carcinomas of the Head and Neck: Targeting PI3K/PTEN/mTOR PathwayJournal of Clinical Oncology, 2013
- Integration of Biomarkers Including Molecular Targeted Therapies in Head and Neck CancerHead and Neck Pathology, 2010
- Activation of the PI3-K/AKT pathway and implications for radioresistance mechanisms in head and neck cancerThe Lancet Oncology, 2008
- Upstream and downstream of mTORGenes & Development, 2004
- PTEN Induces Cell Cycle Arrest by Decreasing the Level and Nuclear Localization of Cyclin D1Molecular and Cellular Biology, 2003
- The phosphatidylinositol 3-Kinase–AKT pathway in human cancerNature Reviews Cancer, 2002